aTYR PHARMA INC (ATYR)

Name: aTYR PHARMA INC (ATYR) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001339970 · Nasdaq · Biological Products, (No Diagnostic Substances)

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, aTYR PHARMA INC reported revenue of $190.0K. Revenue fell 19.1% from the prior annual period.

Key ratios (year ended 2025-12-31)

n/m

Operating margin

n/m

Net margin

-109.8%

Return on year-end equity

-19.1%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-16

Headquarters locality: San Diego · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	n/a	$190.0K	$235.0K	$353.0K	$10.39M	$0	$10.46M	$422.0K	n/a	n/a	n/a
R&D Expense	$47.09M	$60.22M	$54.37M	$42.29M	$42.81M	$23.26M	$17.29M	$14.05M	$20.39M	$30.07M	$42.85M
Operating Income	-$63.86M	-$77.63M	-$67.91M	-$54.92M	-$46.40M	-$34.02M	-$15.91M	-$22.98M	-$32.82M	-$47.15M	-$57.94M
Depreciation & Amortization	$661.0K	$664.0K	$708.0K	$592.0K	$232.0K	$475.0K	$569.0K	$635.0K	$746.0K	$713.0K	$900.0K
EBITDA	-$63.20M	-$76.96M	-$67.21M	-$54.33M	-$46.17M	-$33.54M	-$15.34M	-$22.34M	-$32.07M	-$46.43M	-$57.04M
Net Income	-$60.81M	-$74.12M	-$64.02M	-$50.39M	-$45.34M	-$33.77M	-$16.22M	-$16.22M	-$34.52M	-$48.21M	-$57.85M
EPS (Diluted)	n/a	-$0.80	-$0.86	-$0.94	-$1.60	-$1.77	-$1.77	n/a	n/a	n/a	n/a
Total Assets	$69.83M	$93.00M	$96.83M	$120.65M	$95.79M	$115.54M	$38.73M	$36.19M	$52.75M	$89.36M	$80.52M
Shareholders' Equity	$48.79M	$67.48M	$70.02M	$90.66M	$71.46M	$109.30M	$31.65M	$21.19M	$33.65M	$64.25M	$62.80M
Cash & Equivalents	$16.16M	$10.74M	$11.05M	$22.54M	$9.98M	$2.34M	$16.95M	$9.21M	$22.96M	$21.09M	$38.39M
Operating Cash Flow	-$54.54M	-$61.99M	-$69.12M	-$33.22M	-$41.89M	-$33.08M	-$15.30M	-$20.01M	-$31.06M	-$42.36M	-$52.86M
Capital Expenditures	$279.0K	$77.0K	$65.0K	$4.21M	$1.64M	$192.0K	$202.0K	$79.0K	$594.0K	$1.31M	$600.0K
Free Cash Flow	-$54.82M	-$62.06M	-$69.18M	-$37.44M	-$43.53M	-$33.27M	-$15.50M	-$20.09M	-$31.66M	-$43.68M	-$53.46M
Shares Outstanding	98.09M	98.03M	84.04M	63.29M	29.50M	27.79M	11.02M	3.89M	2.19M	29.79M	23.74M
Weighted Average Diluted Shares	n/a	92.99M	74.26M	53.61M	28.42M	19.08M	9.16M	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.80	-$0.86	-$0.94	-$1.60	-$1.77	-$1.77	n/a	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView